Clinical Implications: Central Obesity, Insulin Resistance, and Cardiovascular Risk The addition of WC analysis in our study offers valuable clinical insight
10.1016/j.phymed.2021.153585 33 LiangW
Can You Go Off and On GLP-1 Weight Loss Drugs
If you have confirmed a true plateau, the next step depends on where you are in the escalation schedule
(2024) Adipex-P highlights of prescribing information, Teva Pharmaceuticals USA (2012) Pharmacotherapy of obesity: an update on the available medications and drugs under investigation, eClinicalMedicine (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Medications for obesity management: Effectiveness and value, Journal of Managed Care & Specialty Pharmacy (2023) Comparison of continuous and intermittent anorectic therapy in obesity, The BMJ (1968) Topiramate and phentermine, StatPearls (2023) Orlistat (marketed as Alli and Xenical) information, U.S
GSTP1 enzyme activities are generally retained in RCC, and might influence resistance to chemotherapy
